CD274 and breast carcinoma: To evaluate the range of variation in normal tissue and to estimate the threshold for pathological gene amplification, we analyzed PD-L1 and cen9 gen copy numbers in 18 benign mammary tissues derived from breast cancer reduction surgeries (Figure 1A).